AKTX

Akari Therapeutics, Plc AKTX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AKTX BDRX PPBT CANF ADAP KZIA BPTSY BLRX NCNA BRNS
6M -13.08 % -48.08 % -76.40 % -66.24 % -16.82 % 81.30 % -40.48 % 42.18 % -96.45 % 93.35 %
YTD -23.14 % -77.53 % -87.15 % -70.39 % -70.34 % -20.23 % -35.28 % -61.74 % -97.85 % 9.68 %
1Y -65.04 % -82.43 % -85.61 % -78.97 % -78.97 % -65.36 % -51.69 % -78.77 % -98.62 % 16.24 %
3Y -91.07 % -99.99 % -98.51 % -92.82 % -83.49 % -86.83 % -99.05 % -88.91 % -99.90 % -50.55 %
5Y -97.58 % -100.00 % -99.33 % -97.18 % -97.99 % -97.68 % -99.97 % -94.04 % -99.98 % -90.35 %
10Y -99.75 % -100.00 % -99.91 % -99.92 % -97.68 % -98.65 % -99.97 % -99.56 % -99.99 % -90.35 %
From the beginning -99.71 % -100.00 % -99.91 % -99.93 % -98.84 % -99.73 % -99.97 % -99.88 % -99.99 % -90.35 %

Dividend